Belfast · Northern Ireland
Retrospective archiveHistorical reports were compiled from linked contemporaneous sources. Dates refer to the events covered.How the archive works

South African Health Products Regulatory Authority approves the use of the Sinopharm BBIBP COVID-19 vaccine for adults aged above 18 years

The South African Health Products Regulatory Authority approves the use of the Sinopharm BBIBP COVID-19 vaccine for adults aged above 18 years.

Herald Premium Archive

This report is for subscribers

Sign in or choose a plan to read this report and the complete Premium retrospective archive.

HealthSouth African Health Products Regulatory Authority approves the use of the Sinopharm BBIBP COVID-19 vaccine for adults aged above 18 years

The South African Health Products Regulatory Authority approves the use of the Sinopharm BBIBP COVID-19 vaccine for adults aged above 18 years.

View Premium plansBrowse free archive reports